Skip to main content

COVID-19 Topic Center

News

News
Per-patient-per-year costs for DLBCL in the United States are considerable, with many patients requiring treatment beyond their first line of therapy, according to a real-world study.
News
Researchers found that a gene therapy drug for SMA appears efficacious and well tolerated in infants older than 7 months, according to a study published online ahead of print in Pediatric Neurology.
News
“The cost of AS-related total medical care significantly increased medical cost savings from 24.85% to 35.52% following TNFi dose reduction,” researchers concluded.
News
President Biden’s nominee for the US Department of Health and Human Services secretary position, Xavier Becerra, has long supported a single-payer system, however, experts wonder if that stance will change if he is appointed.
News
Renowned medical centers are among the quarter of general hospitals that will lose 1% of Medicare payments for one year because their patients have high rates of bedsores, sepsis and other preventable complications.
News
Payments for HIV PrEP medication in the United States totaled more than $2.08 billion in 2018, according to a Centers for Disease Control and Prevention study recently published in Annals of Internal Medicine.
News
“These findings can inform the perceptions and preferences of SMA patients and their caregivers to stakeholders including regulators, patients, patient advocacy group such as CureSMA, and providers,” researchers wrote.
News
“The relatively recent phenomenon of co-existence and clustering of chronic communicable conditions, such as HIV, with highly-prevalent noncommunicable diseases, represents a serious threat for a failure of management of these conditions and increase in their prevalence, further complicated by poor…
News
Fed up with a lack of federal action to lower prescription drug costs, state legislators around the country are pushing bills to penalize drugmakers for unjustified price hikes and to cap payment at much-lower Canadian levels.
News
“Better understanding of nonclinical factors contributing to treatment decisions and efforts to promote greater equity in diabetes management appear to be needed,” said authors of the study.
Back to Top